Gilder Gagnon Howe & CO LLC Vor Biopharma Inc. Transaction History

Gilder Gagnon Howe & CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.04 - $12.23 $381,595 - $772,666	-63,178 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$11.32 - $18.02 $532,753 - $848,075	-47,063 Reduced 42.69%	63,178 $734,000
Q3 2021 Nov 15, 2021	SELL	$12.24 - $20.38 $2.09 Million - $3.47 Million	-170,434 Reduced 60.72%	110,241 $1.73 Million
Q2 2021 Aug 16, 2021	SELL	$18.65 - $38.78 $948,165 - $1.97 Million	-50,840 Reduced 15.34%	280,675 $5.24 Million
Q1 2021 May 17, 2021	BUY	$30.96 - $54.08 $10.3 Million - $17.9 Million	331,515 New	331,515 $14.3 Million

41.2M

9.3K

100

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $32.7M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.